Morgan Stanley’s MGC Diagnostics Corporation MGCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-10
| Closed | – | – | 6883 |
|
|
2017
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 6796 |
|
|
2017
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 6711 |
|
|
2017
Q2 | $0 | Sell |
10
-21
| -68% | -$173 | ﹤0.01% | 6741 |
|
|
2017
Q1 | $0 | Buy |
31
+21
| +210% | +$185 | ﹤0.01% | 6684 |
|
|
2016
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 6627 |
|
|
2016
Q3 | $0 | Sell |
10
-700
| -99% | -$4.83K | ﹤0.01% | 6626 |
|
|
2016
Q2 | $5K | Sell |
710
-6
| -0.8% | -$36 | ﹤0.01% | 6237 |
|
|
2016
Q1 | $4K | Sell |
716
-1
| -0.1% | -$7 | ﹤0.01% | 6341 |
|
|
2015
Q4 | $5K | Buy |
717
+7
| +1% | +$47 | ﹤0.01% | 6392 |
|
|
2015
Q3 | $5K | Sell |
710
-5,308
| -88% | -$30.2K | ﹤0.01% | 6391 |
|
|
2015
Q2 | $34K | Sell |
6,018
-2,226
| -27% | -$13.8K | ﹤0.01% | 5999 |
|
|
2015
Q1 | $59K | Sell |
8,244
-1,601
| -16% | -$11.1K | ﹤0.01% | 5737 |
|
|
2014
Q4 | $63K | Sell |
9,845
-2,500
| -20% | -$16.3K | ﹤0.01% | 5736 |
|
|
2014
Q3 | $80K | Sell |
12,345
-200
| -2% | -$1.55K | ﹤0.01% | 5563 |
|
|
2014
Q2 | $104K | Buy |
12,545
+1,375
| +12% | +$13.6K | ﹤0.01% | 5484 |
|
|
2014
Q1 | $127K | Sell |
11,170
-11,684
| -51% | -$132K | ﹤0.01% | 5341 |
|
|
2013
Q4 | $289K | Buy |
+22,854
| New | +$279K | ﹤0.01% | 4833 |
|
Morgan Stanley's MGCD Position: Q1 2018 in Review
Morgan Stanley sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 10 shares.
Morgan Stanley first reported a position in MGCD in Q4 2013 and held it in 17 quarters. The position peaked at $289K in Q4 2013. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.
- Morgan Stanley reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
- Morgan Stanley sold 10 MGC Diagnostics Corporation shares in Q1 2018.
- Morgan Stanley first reported a position in MGC Diagnostics Corporation in Q4 2013 and held it in 17 quarters.
- Morgan Stanley's MGC Diagnostics Corporation position peaked at $289K in Q4 2013.
- 0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.
Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.